CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shin, D. M.
Right arrow Articles by Hittelman, W. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shin, D. M.
Right arrow Articles by Hittelman, W. N.
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 603-609, June 2001
© 2001 American Association for Cancer Research

p53 Protein Accumulation and Genomic Instability in Head and Neck Multistep Tumorigenesis1

Dong M. Shin2, Navapun Charuruks, Scott M. Lippman, J. Jack Lee, Jae Y. Ro, Waun K. Hong and Walter N. Hittelman

Departments of Thoracic/Head and Neck Medical Oncology [D. M. S., S. M. L., W. K. H.], Pathology [J. Y. R.], Clinical Cancer Prevention [S. M. L.], Biostatistics [J. J. L.], and Clinical Investigations [N. C., W. N. H.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Head and neck cancer develops in a multistep process and is associated with increasing frequencies of p53 alterations and with increasing genomic instability. To study the relationship of p53 alterations and genomic instability during head and neck tumorigenesis, we analyzed p53 protein expression and chromosome 9 and 17 polysomy in 48 squamous cell carcinomas of the head and neck and their adjacent normal epithelium (31 sites), hyperplastic (24 sites), and dysplastic lesions (26 sites). Normal oral epithelium obtained from seven nonsmoking, cancer-free individuals served as negative controls. Six (19%) of 31 lesions in adjacent normal epithelium, 7 (29%) of 24 hyperplastic lesions, 12 (46%) of 26 dysplastic lesions, and 28 (58%) of 48 squamous cell carcinomas expressed p53. In contrast, no normal control epithelium had detectable p53 expression. To determine the relationship between dysregulated p53 expression and genomic instability during tumorigenesis, we compared p53 immunohistochemistry distributions and chromosome polysomy levels (by chromosome in situ hybridization) in different histological groups associated with tissue progression. Although the degree of chromosome polysomy increased for all of the groups during histological progression, lesions with dysregulated p53 expression showed nearly 2–4-fold increased levels of chromosome polysomy. This trend was significant for dysplastic lesions (P = 0.005 and P = 0.002 for chromosomes 9 and 17, respectively) and for squamous cell carcinoma (P = 0.005 and P = 0.002 for chromosomes 9 and 17, respectively). Image analysis studies for 28 p53-expressing tumors and their adjacent premalignant lesions demonstrated a strong spatial correlation between stepwise transitions from low to high p53 expression and increased chromosome polysomy frequencies in 13 (46%) of 28 cases. These findings suggest that altered p53 expression is associated with increased genetic instability in preneoplastic epithelium and may play a driving force for increasing the rate of accumulation of genetic events during head and neck tumorigenesis.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
T. K.S. Ku, D. C. Nguyen, M. Karaman, P. Gill, J. G. Hacia, and D. L. Crowe
Loss of p53 Expression Correlates with Metastatic Phenotype and Transcriptional Profile in a New Mouse Model of Head and Neck Cancer
Mol. Cancer Res., April 1, 2007; 5(4): 351 - 362.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. M. Lippman, J. Sudbo, and W. K. Hong
Oral Cancer Prevention and the Evolution of Molecular-Targeted Drug Development
J. Clin. Oncol., January 10, 2005; 23(2): 346 - 356.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. R. Herzog, T. R. Devereux, B. Pittman, and M. You
Carcinogenic Induction Directs the Selection of Allelic Losses in Mouse Lung Tumorigenesis
Cancer Res., November 15, 2002; 62(22): 6424 - 6429.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D.-S. Yoon, R. P. Wersto, W. Zhou, F. J. Chrest, E. S. Garrett, T. K. Kwon, and E. Gabrielson
Variable Levels of Chromosomal Instability and Mitotic Spindle Checkpoint Defects in Breast Cancer
Am. J. Pathol., August 1, 2002; 161(2): 391 - 397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.